New Delhi, Nov. 5 -- The Union ministry of health and family welfare has proposed immediately suspending licences of those drug manufacturers whose products were classified as "not of standard quality" (NSQ) after failing to meet certain specified parameters. Suspensions will be revoked only after a thorough verification concludes that all parameters are met, it said in a statement on Wednesday. The ministry said that it has proposed adding a clause for immediate "manufacturing license suspension" to the Drugs Rules, 1945. "The proposed amendments seek to enable prompt regulatory intervention upon detection of substandard medicines, prevent their continued manufacture and distribution, and strengthen the mechanism for ensuring compliance wi...